z-logo
open-access-imgOpen Access

Difference in Biomarkers Between COVID-19 Patients and Other Pulmonary Infection Patients

Author(s) -
Jingyi Dai,
Yingrong Du,
Jianpeng Gao,
Jun Zhao,
Lin Wang,
Ying Huang,
Jia-Wei Xia,
Yu Luo,
Shenghao Li,
Edward McNeil
Publication year - 2020
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s257936
Subject(s) - medicine , covid-19 , cohort , prothrombin time , medical record , retrospective cohort study , disease , infectious disease (medical specialty)
The pandemic due to the novel coronavirus disease 2019 (COVID-19) has resulted in an increasing number of patients need to be tested. We aimed to determine if the use of integrated laboratory data can discriminate COVID-19 patients from other pulmonary infection patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here